A Study to Learn About the Study Medicine Called PF-08046032 in People With Advanced Cancers
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
Review of the Literature and Serie of Patients Who Underwent Reconstruction After Wide Local Excision of Nail Apparatus for Melanoma
- Status
- RECRUITING
- Phase
- N/A
A Study to Learn About the Long-Term Health of Adult Participants From a Previous Study of a New Melanoma Treatment
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE2
Evaluation of Hypoxia in Primary Melanoma
- Status
- RECRUITING
- Phase
- N/A
Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Learn About the Study Medicine Called PF-08046031 in Advanced Melanoma and Other Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Study to Evaluate the Efficacy and Safety of IBI363 Monotherapy Compared to Pembrolizumab in Patients With Unresectable Locally Advanced or Metastatic Mucosal or Acral Melanoma Who Had Not Previously Received Systemic Therapy
- Status
- RECRUITING
- Phase
- PHASE2
Statins to Prevent Immune Checkpoint Inhibitor-induced PRogression of AtherosLerosis
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
Different Doses of BI-1607 in Combination With Pembrolizumab and Ipilimumab, in Participants With Unresectable or Metastatic Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Metronomic Cyclophosphamide With Pembrolizumab in Checkpoint Inhibitor Refractory Melanoma
- Status
- RECRUITING
- Phase
- PHASE2
A Phase I/ II Study of Fragmented Autoantigen Stimulated T-cell-immunotherapy Combined with Radiotherapy (FAST-CR)
- Status
- NOT_YET_RECRUITING
- Phase
- EARLY_PHASE1
Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype
- Status
- RECRUITING
- Phase
- NA
Expanded Access Program (EAP) Designed to Provide Access to Botensilimab and Balstilimab Before Regulatory Approval
- Status
- AVAILABLE
- Phase
- N/A
Combination Immunotherapy Targeting Melanoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Phase Ib Study of PRJ1-3024 for Treatment of Advanced or Metastatic Melanoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Trial of Relatlimab, Nivolumab, and Ipilimumab in Patients With Asymptomatic and Symptomatic Melanoma Brain Metastases
- Status
- RECRUITING
- Phase
- PHASE2
HX009+ IN10018 With or Without Standard Chemotherapy for Advanced Solid Tumours
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of GC101 TIL in Advanced Melanoma
- Status
- RECRUITING
- Phase
- PHASE2
Sun Protection and Tanning Awareness in Rural Schools
- Status
- COMPLETED
- Phase
- NA
Phase I/IIa Dose Finding Study of Triplet Regimen of Relatlimab Ipilimumab and NIvolumab in First Line Therapy of Metastatic Melanoma (TRINITY)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2